Scope Fluidics S.A.

Equities

SCP

PLSCPFL00018

Biotechnology & Medical Research

Market Closed - Warsaw S.E. Other stock markets 11:02:02 2024-05-21 am EDT			5-day change	1st Jan Change
182 ^PLN	+10.30%		+11.38%	-7.14%

2023	Scope Fluidics S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
2023	Scope Fluidics S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI

Scope Fluidics S.A. Reports Earnings Results for the First Quarter Ended March 31, 2021

May 14, 2021 at 12:56 am EDT

Scope Fluidics S.A. Announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced operating loss was PLN 3.038 million compared to PLN 1.724 million a year ago. Net loss was PLN 3.043 million compared to PLN 1.731 million a year ago.

Latest news about Scope Fluidics S.A.

Scope Fluidics S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 29	CI
Scope Fluidics S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-10-02	CI
Scope Fluidics S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-30	CI
Scope Fluidics S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
Scope Fluidics S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-16	CI
Bio-Rad Laboratories, Inc. agreed to acquire Curiosity Diagnostics Sp. z o.o. from Scope Fluidics S.A. for $100 million.	22-08-02	CI
Bio-Rad Laboratories, Inc. acquired Curiosity Diagnostics Sp. z o.o. from Scope Fluidics S.A. for approximately $170 million.	22-08-02	CI
Scope Fluidics S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-16	CI
Scope Fluidics S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2021	22-02-14	CI
Scope Fluidics S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-12	CI
An unknown buyer signed letter of intent to acquire Curiosity Diagnostics sp. z o. o. from Scope Fluidics S.A..	21-11-03	CI
Scope Fluidics S.A. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-13	CI
Scope Fluidics S.A. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-14	CI
Scope Fluidics S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2020	21-02-12	CI
Scope Fluidics S.A. announced that it has received PLN 20.4664 million in funding	20-10-29	CI
Scope Fluidics S.A. announced that it has received PLN 13.8924 million in funding from Ipopema Towarzystwo Funduszy Inwestycyjnych S.A.	19-12-12	CI
TTL 1 SP Z O O acquired 7.3% stake in Scope Fluidics S.A.	19-07-03	CI

Chart Scope Fluidics S.A.

Duration

Period

More charts

Company Profile

Scope Fluidics SA is a Poland-based company engaged in the biotechnology. The Company focuses on diagnostic and med-tech solutions. It develops disposable microfluidic systems for the collection of micro-samples of blood, as well as storage of reagents for diagnostic markers. Its projects include PCR ONE system that delivers the bacterial and viral pathogen detection, and BacterOMIC system that delivers information on bacterial susceptibility to antibiotics and on the resistance mechanisms. The Company provides access to laboratories and workshops for developed projects, as well as administrative facilities and services, including financing. In addition, it cooperates with doctors, medical personnel, project managers, engineers and academics.

Sector

Biotechnology & Medical Research

More about the company

Income Statement Evolution

More financial data

Sector Bio Diagnostics & Testing

	1st Jan change	Capi.
SCOPE FLUIDICS S.A.	-7.14%	115M
EXACT SCIENCES CORPORATION	-26.94%	9.41B
IOVANCE BIOTHERAPEUTICS, INC.	+32.16%	2.9B
BGI GENOMICS CO., LTD.	-14.31%	2.16B
VERACYTE, INC.	-20.17%	1.7B
MARAVAI LIFESCIENCES HOLDINGS, INC.	+65.95%	1.51B
CAREDX, INC	+30.14%	814M
SEEGENE, INC.	-1.97%	760M
ADAPTIVE BIOTECHNOLOGIES CORPORATION	-28.37%	529M
CURIOX BIOSYSTEMS CO., LTD	+5.17%	312M

Bio Diagnostics & Testing